Source: European Medicines Agency (EU)
Trimetazidine 35 mg prolonged-release tablets.
| Pharmaceutical Form |
|---|
|
Prolonged-release tablet. Pink, round, biconvex film-coated tablets (diameter approx. 9.0 mm). |
Each prolonged-release tablet contains 35 mg trimetazidine dihydrochloride.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Trimetazidine |
In patients with ischaemic heart disease, trimetazidine acts as a metabolic agent, preserving the myocardial high-energy phosphate intracellular levels. |
| List of Excipients |
|---|
|
Hydroxypropyl methylcellulose |
Blisters (PVC/PVDC/aluminium) in packs of 20, 60 and 120 prolonged release tablets.
Not all pack sizes may be marketed.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
